Celldex Therapeutics | Spese Operative

Operating Expenses Cambiamento Data
AbbVie USD 11.11B 540M 2023-12
Amgen USD 6.93B 2.11B 2023-12
Bristol-Myers Squibb USD 9.62B 984M 2023-12
Celldex Therapeutics USD 51.76M 9M 2023-12
Lumos Pharma USD 8.94M 1.23M 2023-09
Nektar Therapeutics USD 69.01M 2.09M 2023-09
Northwest Biotherapeutics USD 16M 1.75M 2023-09
Pfizer USD 20.8B 4.62B 2023-12
Rigel Pharmaceuticals USD 32.6M 446K 2023-09
Roche Holding CHF 20.02B 5.04B 2023-06



Celldex Therapeutics Spese Operative - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2024.